SOLID DISPERSIONS OF PHARMACEUTICALACTIVE AGENTS IN IN A WATER-SOLUBLECRYSTALLINE MATRIX AND CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONSCONTAINING

• 1. 含有水溶性差的活性成分、表面活性剂和水溶性聚合物的药物组合物 [P] . 中国专利： CN100350911C . 2007.11.28
• 2. 含有水溶性差的活性成分、表面活性剂和水溶性聚合物的药物组合物 [P] . 中国专利： CN1499959A . 2004-05-26
• 3. Lipid particles based on matrix comprising solid and liquid lipid, useful in diagnostics and for controlled release of active agents, especially pharmaceuticals [P] . 德国专利： DE19938371A1 . 2001-02-22

  机译： 基于包含固体和液体脂质的基质的脂质颗粒，可用于诊断和控制活性剂（尤其是药物）的释放

• 4. Lipid particles based on matrix comprising solid and liquid lipid, useful in diagnostics and for controlled release of active agents, especially pharmaceuticals [P] . 德国专利： DE19945203A1 . 2000-12-21

  机译： 基于包含固体和液体脂质的基质的脂质颗粒，可用于诊断和控制活性剂（尤其是药物）的释放

• 5. CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS CONTAINING SOLID DISPERSIONS OF ACTIVE AGENT [P] . IL75490D0 . 1985-10-31

  机译： 含活性成分固体分散体的受控释放药物成分

• 1. Extended tacrolimus release via the combination of lipid-based solid dispersion and HPMC hydrogel matrix tablets [J] . Hui Xu, Li Liu, Xuehui Li, 亚洲药物制剂科学(英文) . 2019,第004期
• 2. Use of seed gums from Tamarindus indica and Cassia fistula as controlled-release agents [J] . Kampanartb Huanbutta, Wancheng Sittikijyothin 亚洲药物制剂科学(英文) . 2018,第005期
• 3. Formulation Study of Controlled-Release Solid Dispersions of Mosapride Citrate [C] . Hye Jin Kim, Sung Soo Kang, Cha Eun Kim, Annual meeting exposition of the Controlled Release Society . 2010
• 4. Controlled release solid dispersion of metoprolol succinate for direct use in the preparation of multiple strengths solid dosage forms. [D] . Renawala, Harshil Kaushik Raksha. 2016
• 5. Extended tacrolimus release via the combination of lipid-based solid dispersion and HPMC hydrogel matrix tablets [O] . Hui Xu, Li Liu, Xuehui Li, 2019
• 6. Application of the Solid Dispersion Method to the Controlled Release of Medicine. III. Control of the Release Rate of Slightly Water Soluble Medicine from Solid Dispersion Granules. [O] . Hiroshi YUASA, Hiroyuki TAKAHASHI, Tetsuya OZEKI, 1993
• 7. Free Boundary Problems in Controlled Release Pharmaceuticals. 2. Swelling-Controlled Release [R] . Cohen, D. S., Erneux, T. 1988

• 1. The Preparation of Salbutamol Sulfate Controlled Release TabletsCoated with Cellulose Acetate Aqueous Dispersion [J] . ZhangFengyu ,WuTao ,PanWeisan . 中国药学：英文版 . 2001,第2期
• 2. PVP/Clay/Vanadium Oxide Nanocomposites Development and Characterization for Potential Use as Controlled Drug Release Matrix in Diabetes’ Treatment [J] . Dario Barreto Reino de Almeida ,Maria Inês Bruno Tavares . 材料科学与应用期刊（英文） . 2019,第12期
• 3. Controlled-Release Analysis of Potassium Permanganate Using PMMA Matrix [J] . Jude O. Ighere ,Ramesh C. Chawla . 矿物质和材料特性和工程（英文） . 2014,第6期
• 4. 黑青药基质中药物释放的动力学与热力学研究 [C] . 梁文权 . 新剂型评价会议 . -1
• 5. 普洱茶水溶性基质成分对关键香气释放的影响 [A] . 翁彦如 . 2019